预测PICU脓毒症患者脓毒症相关脑病风险列线图的开发与验证:多中心回顾性队列研究
该多中心回顾性研究纳入中国山东三家医院PICU的613例脓毒症患者(2017年1月至2022年5月),237例(38.7%)发生脓毒症相关脑病(SAE)。采用LASSO回归筛选变量,构建预测SAE的列线图,训练队列251例,两个独立验证队列分别为193例和169例。列线图在训练队列AUC 0.82(95%CI 0.76–0.88),验证队列1 AUC 0.80(95%CI 0.74–0.86),验证队列2 AUC 0.81(95%CI 0.73–0.88);校准曲线显示预测值与观测值高度一致,决策曲线分析提示较高净临床获益。作者认为该列线图及在线计算器可能有助于临床医生早期发现和干预SAE。
要点
- 在PICU脓毒症患者中,SAE发生率为38.7%(237/613),与呼吸频率、血尿素氮、活化部分凝血活酶时间、动脉血二氧化碳分压及小儿危重病例评分相关。
- 列线图预测SAE的AUC在训练队列为0.82(95%CI 0.76–0.88,敏感度65.6%,特异度88.8%),验证队列1为0.80(95%CI 0.74–0.86,敏感度75.0%,特异度74.3%),验证队列2为0.81(95%CI 0.73–0.88,敏感度69.1%,特异度83.3%)。
- 校准曲线显示预测SAE概率与观测值高度一致,决策曲线分析提示列线图带来较高净临床获益。
- 作者认为该列线图及在线计算器可能辅助临床医生早期识别和干预PICU脓毒症患者的SAE。
适用人群与场景
- 中国山东三家医院PICU收治的脓毒症患者,年龄符合PICU收治标准;研究共筛查790例,最终纳入613例。
- 研究为回顾性多中心队列,时间范围为2017年1月至2022年5月;训练队列251例,验证队列1为193例,验证队列2为169例。
研究设计与关键结果
- 研究类型:多中心回顾性队列研究;最终纳入613例PICU脓毒症患者,来自三家医院;训练队列251例,两个独立验证队列分别为193例和169例。
- 总体SAE发生率为38.7%(237/613);SAE发生与呼吸频率、血尿素氮、活化部分凝血活酶时间、动脉血二氧化碳分压及小儿危重病例评分相关。
- 采用LASSO回归筛选变量并构建列线图;训练队列AUC 0.82(95%CI 0.76–0.88),敏感度65.6%,特异度88.8%;验证队列1 AUC 0.80(95%CI 0.74–0.86),敏感度75.0%,特异度74.3%;验证队列2 AUC 0.81(95%CI 0.73–0.88),敏感度69.1%,特异度83.3%。
- 校准曲线显示列线图预测的SAE概率与观测值高度一致;决策曲线分析提示列线图带来较高净临床获益。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究(预测模型开发与验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该新型列线图及在线计算器在预测PICU脓毒症患者SAE发生风险方面表现出一定性能,可能辅助临床医生早期发现和干预SAE。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with sepsis-associated encephalopathy (SAE) have higher mortality rates and longer ICU stays. Predictors of SAE are yet to be identified. We aimed to establish an effective and simple-to-use nomogram for the individual prediction of SAE in patients with sepsis admitted to pediatric intensive care unit (PICU) in order to prevent early onset of SAE.
METHODS: In this retrospective multicenter study, we screened 790 patients with sepsis admitted to the PICU of three hospitals in Shandong, China. Least absolute shrinkage and selection operator regression was used for variable selection and regularization in the training cohort. The selected variables were used to construct a nomogram to predict the risk of SAE in patients with sepsis in the PICU. The nomogram performance was assessed using discrimination and calibration.
RESULTS: From January 2017 to May 2022, 613 patients with sepsis from three centers were eligible for inclusion in the final study. The training cohort consisted of 251 patients, and the two independent validation cohorts consisted of 193 and 169 patients. Overall, 237 (38.7%) patients developed SAE. The morbidity of SAE in patients with sepsis is associated with the respiratory rate, blood urea nitrogen, activated partial thromboplastin time, arterial partial pressure of carbon dioxide, and pediatric critical illness score. We generated a nomogram for the early identification of SAE in the training cohort (area under curve [AUC] 0.82, 95% confidence interval [CI] 0.76-0.88, sensitivity 65.6%, specificity 88.8%) and validation cohort (validation cohort 1: AUC 0.80, 95% CI 0.74-0.86, sensitivity 75.0%, specificity 74.3%; validation cohort 2: AUC 0.81, 95% CI 0.73-0.88, sensitivity 69.1%, specificity 83.3%). Calibration plots for the nomogram showed excellent agreement between SAE probabilities of the observed and predicted values. Decision curve analysis indicated that the nomogram conferred a high net clinical benefit.
CONCLUSIONS: The novel nomogram and online calculator showed performance in predicting the morbidity of SAE in patients with sepsis admitted to the PICU, thereby potentially assisting clinicians in the early detection and intervention of SAE.
参考来源
- Wang G, Jiang X, Fu Y, et al. Development and validation of a nomogram to predict the risk of sepsis-associated encephalopathy for septic patients in PICU: a multicenter retrospective cohort study. J Intensive Care. 2024. PMID: 38378667. doi:10.1186/s40560-024-00721-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。